Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Marburg and Ravn Virus Infections Do Not Cause Observable Disease in Ferrets.

Wong G, Zhang Z, He S, de La Vega MA, Tierney K, Soule G, Tran K, Fernando L, Qiu X.

J Infect Dis. 2018 Jun 8. doi: 10.1093/infdis/jiy245. [Epub ahead of print]

PMID:
29889278
2.

High Spending Growth Rates For Key Diseases In 2000-14 Were Driven By Technology And Demographic Factors.

Dunn A, Whitmire B, Batch A, Fernando L, Rittmueller L.

Health Aff (Millwood). 2018 Jun;37(6):915-924. doi: 10.1377/hlthaff.2017.1688.

PMID:
29863919
3.

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model.

Blanco JCG, Pletneva LM, McGinnes-Cullen L, Otoa RO, Patel MC, Fernando LR, Boukhvalova MS, Morrison TG.

Nat Commun. 2018 May 15;9(1):1904. doi: 10.1038/s41467-018-04216-6.

4.
5.

Ranking Enzyme Structures in the PDB by Bound Ligand Similarity to Biological Substrates.

Tyzack JD, Fernando L, Ribeiro AJM, Borkakoti N, Thornton JM.

Structure. 2018 Apr 3;26(4):565-571.e3. doi: 10.1016/j.str.2018.02.009. Epub 2018 Mar 15.

6.

Chiari malformation type 1 presenting as unilateral progressive foot drop: a case report and review of literature.

Jayamanne C, Fernando L, Mettananda S.

BMC Pediatr. 2018 Feb 7;18(1):34. doi: 10.1186/s12887-018-1028-8. Review.

7.

Poly(2-propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles as a targeted antigen delivery system to direct either CD4+ or CD8+ T cell activation.

Yang L, Bracho-Sanchez E, Fernando LP, Lewis JS, Carstens MR, Duvall CL, Keselowsky BG.

Bioeng Transl Med. 2017 Jul 11;2(2):202-211. doi: 10.1002/btm2.10068. eCollection 2017 Jun.

8.

NS 1 lasts longer than the dengue virus nucleic acid in the clinically suspected patients with dengue fever and dengue haemorrhagic fever.

Sirisena N, Noordeen F, Fernando L.

Virusdisease. 2017 Sep;28(3):341-344. doi: 10.1007/s13337-017-0401-9. Epub 2017 Sep 20.

PMID:
29291223
9.

Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery.

Fernando LP, Lewis JS, Evans BC, Duvall CL, Keselowsky BG.

J Biomed Mater Res A. 2018 Apr;106(4):1022-1033. doi: 10.1002/jbm.a.36298. Epub 2017 Dec 21.

PMID:
29164777
10.

Seven-Year Follow-up of Full-Arch Prostheses Supported by Four Implants: A Prospective Study.

Ayub KV, Ayub EA, Lins do Valle A, Bonfante G, Pegoraro T, Fernando L.

Int J Oral Maxillofac Implants. 2017 Nov/Dec;32(6):1351-1358. doi: 10.11607/jomi.5312.

PMID:
29140379
11.

Assisted dying for patients with psychiatric disorders.

Fernando L.

CMAJ. 2017 Mar 13;189(10):E413. doi: 10.1503/cmaj.732757. No abstract available.

12.

Comparison of Two Adsorbent Based de-Bittering Procedures for Neem (Azadirachta indica A. Juss) Tea- Effect on Polyphenols, Anti-Oxidant Capacity, Color and Volatile Profile.

Datta A, Grün IU, Kwasniewski MT, Fernando LN.

Plant Foods Hum Nutr. 2017 Mar;72(1):88-95. doi: 10.1007/s11130-016-0595-9.

PMID:
28091970
13.

Effect of Climatic Factors and Population Density on the Distribution of Dengue in Sri Lanka: A GIS Based Evaluation for Prediction of Outbreaks.

Sirisena P, Noordeen F, Kurukulasuriya H, Romesh TA, Fernando L.

PLoS One. 2017 Jan 9;12(1):e0166806. doi: 10.1371/journal.pone.0166806. eCollection 2017.

14.

Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques.

Wong G, Qiu X, de La Vega MA, Fernando L, Wei H, Bello A, Fausther-Bovendo H, Audet J, Kroeker A, Kozak R, Tran K, He S, Tierney K, Soule G, Moffat E, Günther S, Gao GF, Strong J, Embury-Hyatt C, Kobinger G.

J Infect Dis. 2016 Oct 15;214(suppl 3):S281-S289. Epub 2016 Sep 19.

15.

An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.

Wu S, Kroeker A, Wong G, He S, Hou L, Audet J, Wei H, Zhang Z, Fernando L, Soule G, Tran K, Bi S, Zhu T, Yu X, Chen W, Qiu X.

J Infect Dis. 2016 Oct 15;214(suppl 3):S326-S332. Epub 2016 Aug 4. Erratum in: J Infect Dis. 2017 Jan 1;215(1):165.

16.

Redesigning pictographs for patients with low health literacy and establishing preliminary steps for delivery via smart phones.

Wolpin SE, Nguyen JK, Parks JJ, Lam AY, Morisky DE, Fernando L, Chu A, Berry DL.

Pharm Pract (Granada). 2016 Apr-Jun;14(2):686. doi: 10.18549/PharmPract.2016.02.686. Epub 2016 Jun 15.

17.

Two-mAb cocktail protects macaques against the Makona variant of Ebola virus.

Qiu X, Audet J, Lv M, He S, Wong G, Wei H, Luo L, Fernando L, Kroeker A, Fausther Bovendo H, Bello A, Li F, Ye P, Jacobs M, Ippolito G, Saphire EO, Bi S, Shen B, Gao GF, Zeitlin L, Feng J, Zhang B, Kobinger GP.

Sci Transl Med. 2016 Mar 9;8(329):329ra33. doi: 10.1126/scitranslmed.aad9875.

18.

Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommittee.

O'Leary MF, Dunbar NM, Kim HC, Draper NL, Linenberger M, Schwartz J, Miller Y, Murtaugh A, West FB, Fernando LP, Park YA.

J Clin Apher. 2016 Dec;31(6):529-534. doi: 10.1002/jca.21445. Epub 2016 Jan 13.

PMID:
26762291
19.

Immune Response to Marburg Virus Angola Infection in Nonhuman Primates.

Fernando L, Qiu X, Melito PL, Williams KJ, Feldmann F, Feldmann H, Jones SM, Alimonti JB.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S234-41. doi: 10.1093/infdis/jiv095. Epub 2015 May 9.

PMID:
25957966
20.

Occurrence of Polyphenols, Organic Acids, and Sugars among Diverse Elderberry Genotypes Grown in Three Missouri (USA) Locations.

Thomas AL, Byers PL, Gu S, Avery JD Jr, Kaps M, Datta A, Fernando L, Grossi P, Rottinghaus GE.

Acta Hortic. 2015 Jan 12;1061:147-154.

21.

VSVΔG/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection.

Williams KJ, Qiu X, Fernando L, Jones SM, Alimonti JB.

Viral Immunol. 2015 Feb;28(1):51-61. doi: 10.1089/vim.2014.0069.

PMID:
25494457
22.

Cardiovascular disease in Latin America: the growing epidemic.

Fernando L, Pamela S, Alejandra L.

Prog Cardiovasc Dis. 2014 Nov-Dec;57(3):262-7. doi: 10.1016/j.pcad.2014.07.007. Epub 2014 Aug 4.

PMID:
25443823
23.

A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection.

Choi JH, Jonsson-Schmunk K, Qiu X, Shedlock DJ, Strong J, Xu JX, Michie KL, Audet J, Fernando L, Myers MJ, Weiner D, Bajrovic I, Tran LQ, Wong G, Bello A, Kobinger GP, Schafer SC, Croyle MA.

Mol Pharm. 2015 Aug 3;12(8):2712-31. doi: 10.1021/mp500646d. Epub 2014 Nov 14.

24.

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents.

Wong G, Audet J, Fernando L, Fausther-Bovendo H, Alimonti JB, Kobinger GP, Qiu X.

Vaccine. 2014 Sep 29;32(43):5722-9. doi: 10.1016/j.vaccine.2014.08.028. Epub 2014 Aug 27.

PMID:
25173474
25.

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP.

Nature. 2014 Oct 2;514(7520):47-53. doi: 10.1038/nature13777. Epub 2014 Aug 29.

26.

Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory.

Alimonti J, Leung A, Jones S, Gren J, Qiu X, Fernando L, Balcewich B, Wong G, Ströher U, Grolla A, Strong J, Kobinger G.

Sci Rep. 2014 Jul 25;4:5824. doi: 10.1038/srep05824.

27.

Expediency of dengue illness classification: The Sri Lankan perspective.

Tissera H, Weeraman J, Amarasinghe A, Wijewickrama A, Palihawadana P, Fernando L.

WHO South East Asia J Public Health. 2014 Jan-Mar;3(1):5-7. doi: 10.4103/2224-3151.206884. No abstract available.

28.

Dynamic transcriptional response of Escherichia coli to inclusion body formation.

Baig F, Fernando LP, Salazar MA, Powell RR, Bruce TF, Harcum SW.

Biotechnol Bioeng. 2014 May;111(5):980-99. doi: 10.1002/bit.25169. Epub 2014 Jan 30.

29.

Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb.

Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, Alimonti JB, Kobinger GP.

Sci Rep. 2013 Nov 28;3:3365. doi: 10.1038/srep03365.

30.

The effects of protein solubility on the RNA Integrity Number (RIN) for recombinant Escherichia coli.

Salazar MA, Fernando LP, Baig F, Harcum SW.

Biochem Eng J. 2013 Oct 15;79:129-135. doi: 10.1016/j.bej.2013.07.011.

31.

mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms.

Qiu X, Wong G, Fernando L, Audet J, Bello A, Strong J, Alimonti JB, Kobinger GP.

Sci Transl Med. 2013 Oct 16;5(207):207ra143. doi: 10.1126/scitranslmed.3006605.

32.

The million mutation project: a new approach to genetics in Caenorhabditis elegans.

Thompson O, Edgley M, Strasbourger P, Flibotte S, Ewing B, Adair R, Au V, Chaudhry I, Fernando L, Hutter H, Kieffer A, Lau J, Lee N, Miller A, Raymant G, Shen B, Shendure J, Taylor J, Turner EH, Hillier LW, Moerman DG, Waterston RH.

Genome Res. 2013 Oct;23(10):1749-62. doi: 10.1101/gr.157651.113. Epub 2013 Jun 25.

33.

Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs.

Qiu X, Wong G, Fernando L, Ennis J, Turner JD, Alimonti JB, Yao X, Kobinger GP.

J Virol. 2013 Jul;87(13):7754-7. doi: 10.1128/JVI.00173-13. Epub 2013 Apr 24.

34.

Influence of diffusive transport on the structural evolution of W/O/W emulsions.

Sameh H, Wafa E, Sihem B, Fernando LC.

Langmuir. 2012 Dec 21;28(51):17597-608. doi: 10.1021/la303469j. Epub 2012 Dec 12.

PMID:
23176152
35.

The relative brightness of PEG lipid-conjugated polymer nanoparticles as fluid-phase markers in live cells.

Fernando LP, Kandel PK, Ackroyd PC, Christensen KA.

Anal Bioanal Chem. 2012 Dec;404(10):3003-14. doi: 10.1007/s00216-012-6441-5. Epub 2012 Sep 30.

36.

Surface-enhanced raman scattering detection of pH with silica-encapsulated 4-mercaptobenzoic acid-functionalized silver nanoparticles.

Wang F, Widejko RG, Yang Z, Nguyen KT, Chen H, Fernando LP, Christensen KA, Anker JN.

Anal Chem. 2012 Sep 18;84(18):8013-9. doi: 10.1021/ac3018179. Epub 2012 Aug 31.

PMID:
22881392
37.

Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection.

Qiu X, Fernando L, Melito PL, Audet J, Feldmann H, Kobinger G, Alimonti JB, Jones SM.

PLoS Negl Trop Dis. 2012;6(3):e1575. doi: 10.1371/journal.pntd.0001575. Epub 2012 Mar 20.

38.

Population dynamics of Aceria guerreronis (Acari: Eriophyidae) and its predatory mite, Neoseiulus baraki (Acari: Phytoseiidae) in two coconut growing areas in Sri Lanka.

Aratchige NS, Fernando LC, Waidyarathne KP, Chandrasiri KA.

Exp Appl Acarol. 2012 Apr;56(4):319-25. doi: 10.1007/s10493-012-9519-z. Epub 2012 Feb 11.

PMID:
22327463
39.

Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.

Qiu X, Alimonti JB, Melito PL, Fernando L, Ströher U, Jones SM.

Clin Immunol. 2011 Nov;141(2):218-27. doi: 10.1016/j.clim.2011.08.008. Epub 2011 Aug 31.

PMID:
21925951
40.

The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola.

Grolla A, Jones SM, Fernando L, Strong JE, Ströher U, Möller P, Paweska JT, Burt F, Pablo Palma P, Sprecher A, Formenty P, Roth C, Feldmann H.

PLoS Negl Trop Dis. 2011 May;5(5):e1183. doi: 10.1371/journal.pntd.0001183. Epub 2011 May 24.

41.

Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.

Dwyre DM, Fernando LP, Holland PV.

Vox Sang. 2011 Jan;100(1):92-8. doi: 10.1111/j.1423-0410.2010.01426.x. Review.

PMID:
21175659
42.

Incorporating functionalized polyethylene glycol lipids into reprecipitated conjugated polymer nanoparticles for bioconjugation and targeted labeling of cells.

Kandel PK, Fernando LP, Ackroyd PC, Christensen KA.

Nanoscale. 2011 Mar;3(3):1037-45. doi: 10.1039/c0nr00746c. Epub 2010 Dec 13.

43.

Mechanism of cellular uptake of highly fluorescent conjugated polymer nanoparticles.

Fernando LP, Kandel PK, Yu J, McNeill J, Ackroyd PC, Christensen KA.

Biomacromolecules. 2010 Oct 11;11(10):2675-82. doi: 10.1021/bm1007103.

44.

Nanoscale 3D tracking with conjugated polymer nanoparticles.

Yu J, Wu C, Sahu SP, Fernando LP, Szymanski C, McNeill J.

J Am Chem Soc. 2009 Dec 30;131(51):18410-4. doi: 10.1021/ja907228q.

PMID:
20028148
45.

Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative.

Smith D, Lu Q, Yuan S, Goldfinger D, Fernando LP, Ziman A.

Vox Sang. 2010 Jan;98(1):29-36. doi: 10.1111/j.1423-0410.2009.01228.x. Epub 2009 Aug 20.

PMID:
19695013
46.

Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses.

Qiu X, Fernando L, Alimonti JB, Melito PL, Feldmann F, Dick D, Ströher U, Feldmann H, Jones SM.

PLoS One. 2009;4(5):e5547. doi: 10.1371/journal.pone.0005547. Epub 2009 May 14.

47.

Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort.

Pere D, Ignacio SL, Ramón T, Fernando L, Alberto T, Pompeyo V, Juan G, M José G, Paloma G, Antonio V, Jaime C, Esteban R, Bernardino R, M Luisa GA, Trinitario S, Ferran T, Juan Ramón L, Myriam G.

Open AIDS J. 2008;2:26-38. doi: 10.2174/1874613600802010026. Epub 2008 Mar 24.

48.

Standardized protocol to identify high-risk patients undergoing therapeutic apheresis procedures.

Lu Q, Nedelcu E, Ziman A, Bumerts P, Fernando L, Schiller G.

J Clin Apher. 2008;23(3):111-5. doi: 10.1002/jca.20167.

PMID:
18521857
49.

Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: an effective protocol.

Nedelcu E, Ziman A, Fernando LP, Cook K, Bumerts P, Schiller G.

J Clin Apher. 2008;23(2):66-73. doi: 10.1002/jca.20159.

PMID:
18286495
50.

The creation of stable cell lines expressing Ebola virus glycoproteins and the matrix protein VP40 and generating Ebola virus-like particles utilizing an ecdysone inducible mammalian expression system.

Melito PL, Qiu X, Fernando LM, deVarennes SL, Beniac DR, Booth TF, Jones SM.

J Virol Methods. 2008 Mar;148(1-2):237-43. doi: 10.1016/j.jviromet.2007.12.004. Epub 2008 Feb 1.

PMID:
18242720

Supplemental Content

Loading ...
Support Center